Non-HDL Cholesterol Profile

The Non-HDL Cholesterol Profile is used for cardiovascular risk stratification and as a treatment target in dyslipidemia management. It is especially useful in settings of hypertriglyceridemia, metabolic syndrome, or diabetes where calculated low-density lipoprotein cholesterol (LDL-C) may be less dependable. Because non–HDL-C equals total cholesterol minus HDL-C, it represents cholesterol carried by atherogenic particles (VLDL, IDL, LDL, and lipoprotein[a]). Therapeutic thresholds for non–HDL-C are commonly set 30 mg/dL above the corresponding LDL-C goals, and the metric is followed to evaluate dietary interventions and lipid-lowering pharmacotherapy.

Cholesterol is a fundamental lipid required for cell membrane integrity, steroid hormone production, and bile acid formation. Because it is water-insoluble, it circulates in plasma within lipoprotein particles composed of lipids and apolipoproteins. The principal lipoprotein classes are very-low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL). Excess cholesterol in atherogenic particles, particularly LDL, fosters deposition within arterial walls, promoting atherosclerosis and increasing the risk of ischemic heart disease and stroke. Most cholesterol demand is met by hepatic synthesis, but dietary intake—especially animal fats—can raise circulating atherogenic lipoproteins, and inherited disorders can further elevate levels.